Kindstar Globalgene Technology, Inc. (9960.HK)
Market: HKEX |
Currency: HKD
Address: Biolake D2-1
Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People's Republic of China. The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology diseases. It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research testing laboratories. Kindstar Globalgene Technology, Inc. was founded in 2003 and is headquartered in Wuhan, the People's Republic of China.
Show more
📈 Kindstar Globalgene Technology, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
<0%
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2025 |
- |
$0.023800 |
- |
2025-06-09 |
- |
Dividend payout |
|
Total Amount for 2025: $0.023800 |
| 2024 |
- |
$0.028400 |
- |
2024-06-07 |
- |
Dividend payout |
|
Total Amount for 2024: $0.028400 |
📅 Earnings & EPS History for Kindstar Globalgene Technology, Inc.
| Date | Reported EPS |
|---|
| 2025-08-25 (estimated upcoming) | - |
| 2025-03-24 | - |
| 2023-08-17 | - |
| 2023-03-26 | - |
| 2022-08-14 | - |
| 2022-03-24 | - |
| 2021-08-29 | - |
| 2021-02-24 | - |
📰 Related News & Research
No related articles found for "kindstar globalgene".
